Keyphrases
Epidermal Growth Factor Receptor
100%
Epidermal Growth Factor Receptor Inhibitors
100%
Skin Toxicity
100%
Drug-receptor Interaction
100%
Cetuximab
60%
Small Molecules
40%
Advanced Stage
20%
Tumor
20%
Binding Affinity
20%
Epithelial Cancer
20%
Quality of Life
20%
Systemic Dose
20%
Current Treatment
20%
Sebaceous Gland
20%
Hair Follicle
20%
Treatment Strategy
20%
Human Skin
20%
Anticancer Treatment
20%
Symptom Reduction
20%
In Silico Docking
20%
Epidermal Growth Factor Receptor Signaling
20%
Slow Release
20%
A431
20%
Biodegradable Nanoparticles
20%
Keratinocyte Cell Line
20%
Panitumumab
20%
Anti-epidermal Growth Factor Receptor Monoclonal Antibodies
20%
Medicine and Dentistry
Epidermal Growth Factor Receptor
100%
Epidermal Growth Factor Receptor Kinase Inhibitor
100%
Skin Toxicity
100%
Drug Receptor Binding
100%
Cetuximab
50%
Malignant Neoplasm
16%
Neoplasm
16%
Side Effect
16%
Ex Vivo
16%
Monoclonal Antibody
16%
Quality of Life
16%
Binding Affinity
16%
In Silico
16%
Deterioration
16%
Hair Follicle
16%
Sebaceous Gland
16%
Keratinocyte Cell Line
16%
Anti-Epidermal Growth Factor Receptor
16%
Panitumumab
16%
Nanoparticle
16%
Pharmacology, Toxicology and Pharmaceutical Science
Epidermal Growth Factor Receptor
100%
Epidermal Growth Factor Receptor Kinase Inhibitor
100%
Skin Toxicity
100%
Drug Receptor Interactions
100%
Cetuximab
42%
Neoplasm
14%
Monoclonal Antibody
14%
Side Effect
14%
Malignant Neoplasm
14%
Nanoparticle
14%
Deterioration
14%
Panitumumab
14%